FDA Adverse Event Injury Summary report: N

OT PING METER

MDR report key: 4112430 · Received September 24, 2014

Report

Report Number
2939301-2014-25168
Event Type
Injury
Date Received
September 24, 2014
Date of Event
August 11, 2014
Report Date
September 4, 2014
Manufacturer
LIFESCAN EUROPE, A DIVISION OF CILAG GMBH INTL
Product Code
NBW
PMA / PMN Number
K082590
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
NJ, US
Reporter Occupation
PATIENT

Narratives

Description of Event or Problem · 1

ON (B)(6) 2014, THE LAY USER/PATIENT CONTACTED LIFESCAN (LFS) ALLEGING THAT HER ONETOUCH PING METER WAS READING INACCURATELY HIGH. THE COMPLAINT WAS CLASSIFIED BASED ON THE CUSTOMER CARE ADVOCATE¿S (CCA) DOCUMENTATION. THE PATIENT CLAIMED THE ALLEGED ISSUE BEGAN ON (B)(6) 2014 AT APPROXIMATELY NOON. THE PATIENT REPORTED TESTING ON THE SUBJECT METER AND OBSERVED VALUES OF ¿58, 60 MG/DL¿ WHICH SHE FELT WAS INACCURATELY LOW AS COMPARED TO HOW SHE FELT. IT IS NOT KNOWN WHAT RANGE THE PATIENT CONSIDERS TO BE NORMAL. THE PATIENT MANAGES HER DIABETES WITH ORAL MEDICATION AND DIET/EXERCISE AND SHE REPORTED THAT IN RESPONSE TO THE LOW READING AT 6PM THAT SAME DAY, SHE CONSUMED MORE FOOD/DRINK. THE PATIENT CLAIMED THAT 4-5 HOURS LATER, SHE DEVELOPED SYMPTOMS OF ¿SWEATING AND HEART RACING¿ BUT DESPITE HER SYMPTOMS, SHE DENIED RECEIVING ANY FORM OF MEDICAL INTERVENTION. AT THE TIME OF TROUBLESHOOTING THE CCA CONFIRMED THE METER WAS SET TO THE CORRECT UNIT OF MEASURE, THE SUBJECT TEST STRIPS WERE IN GOOD CONDITION, IT IS NOT KNOWN IF QUALITY CONTROL TESTING WAS PERFORMED. REPLACEMENT PRODUCTS HAVE BEEN SENT TO THE PATIENT AND SUBJECT PRODUCTS ARE PENDING RETURN FOR INVESTIGATION. THIS COMPLAINT IS BEING REPORTED BECAUSE, THE PATIENT REPORTEDLY DEVELOPED SYMPTOMS SUGGESTIVE OF A SERIOUS INJURY AFTER THE ALLEGED METER ISSUE BEGAN.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
593230 OT PING METER GLUCOSE MONITORING SYS/KIT NBW LIFESCAN EUROPE, A DIVISION OF CILAG GMBH INTL 3658549

Patients

Seq Age Sex Outcome Treatment
1 62 YR Life Threatening